chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Arm where I got vaccine quit working  for over a month.  Malaise, unable to eat, brain became foggy,  After 2nd shot, explosive diarrhea for over 4 months.  Susceptible to all viruses that I came in contact with. Far more ill than normal.  Caught things that I normally don't.  Immune system compromised.  Caused anger issues. Caused increased reaction to cold.  More vomiting.   Cognitive issues.  Still trying to get those back.
very hot and uncomfortable ear for 24 hours; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other caregiver and describes the occurrence of EAR DISCOMFORT (very hot and uncomfortable ear for 24 hours) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced EAR DISCOMFORT (very hot and uncomfortable ear for 24 hours). At the time of the report, EAR DISCOMFORT (very hot and uncomfortable ear for 24 hours) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication   Most recent FOLLOW-UP information incorporated above includes: On 01-May-2021: TCR form - does not recall reporting this
DTaP-IPV component of Pentacel was given minus the ActHIB in error/no ae; Initial information received on 05-Dec-2019 regarding an unsolicited valid serious case received from a other health professional.  This case involves a 8 months old female patient who was vaccinated with DTaP-IPV component of vaccine DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] without ACT-HIB in error (inappropriate reconstitution technique) (frequency once) lot number: U6396AA, expiry date: 14-Oct-2020 via intramuscular route in the upper right leg on 04-Dec-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included VARICELLA ZOSTER VACCINE (VARICELLA VACCINE) for Immunisation.  It was a case of actual medication error due to inappropriate reconstitution technique.  At the time of reporting, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive and Module VI of the Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
WARM SENSATION TO THE ENTIRE UPPER ARM AND GOES DOWN TO THE ELBOW; This spontaneous report received from a patient concerned an 82 year old female. The patient's weight was 145 pounds, and height was 65 inches. The patient's past medical history included uterine cancer, and uterine surgery, and concurrent conditions included alcohol user, non smoker, and penicillin allergy, and other pre-existing medical conditions included the patient has the allergy of certain anesthesia's due to insufficient levels of enzymes dibucaine and pseudo-cholinesterase, and reported that she almost died on the operating table due to that. the patient did not have any history of drug abuse or illicit drug use. patient take estrogen replacement. The patient experienced drug allergy when treated with cinchocaine, and morphine. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 204A21A, and expiry: 07-AUG-2021) dose was not reported, administered on 20-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced warm sensation to the entire upper arm and goes down to the elbow. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from warm sensation to the entire upper arm and goes down to the elbow. This report was non-serious.
Developed left calf pain morning of 10/21 which continued to worsen. Swelling started slightly later that day and worsened. Low grade fever started 10/24. Admitted 10/25 when she could not bear weight at all. Was seen in ED 10/23 with nl CBC and ESR, slightly high CRP, nl CK, nl Doppler ultrasound of calf and sent home.  Was seen in office 10/24, refused ED return.  Seen again in office again 10/25, had xray (nl bone, +soft tissue swelling) and admitted to hosp.  STat MRI showed myositis (ESR up to 35). IV clindamycin started and responded well with discharge 24 hours later.  generalized hives on day 3 prompted antibiotic change to Bactrim and cefdinir.
Tinnitus began in both ears and swolen lymph nodes above collar bone on side of shot.
I had chills, body aches, fever, cough, nasal congestion, fatigue, sore throat, and loss of appetite. I tested positive for COVID-19. My doctor put me on PAXLOVID, and I started to feel better. By 12/19/2022 I tested negative. I still don't have the same level of energy and a little cough.
For the past 6 days now, I've been having the following symptoms: headaches, fever, fatigue, night sweats, chills, loss of appetite, and a cough.
Approximately 8 hours after receiving the booster shot, hives became present all over the body. She took 1 Zyrtec, but there was no relief. Because hives had not let up by the next morning, she took 2 Bendaryl. The Benadryl made the hives tolerable, but the hives are still present (though better) as of 9/7 (4 days post-injection).
Injection site initially itchy. That evening it was red and swollen. Over next 2 days it changed to a bruised look.
Tested positive for covid after being vaccinated; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Tested positive for covid after being vaccinated) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive for covid after being vaccinated). At the time of the report, SARS-COV-2 TEST POSITIVE (Tested positive for covid after being vaccinated) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive Positive.         The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable  No concomitant medications reported. No treatment reported.
This is a spontaneous report from a contactable consumer from a Pfizer-sponsored program. A currently 74-year-old female patient received the PREVENAR 13, via an unspecified route of administration in the arm on an unspecified date at a single dose for immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced slight arm pain/pain in my arm, redness, and swollen arm. The patient reported that she "usually did not get any vaccines but I did get one a few years ago and the same side effect were slight arm pain and redness". The clinical outcome of the events was unknown. No follow-up attempts are possible; information about batch/lot number cannot be obtained.
Severe swelling and pain in left arm, tingling in all extremities, pain worse at night, affecting ambulating
Missed 2nd dose > 6 months after first shot; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed 2nd dose > 6 months after first shot) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Sep-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed 2nd dose > 6 months after first shot). On 08-Sep-2021, PRODUCT DOSE OMISSION ISSUE (Missed 2nd dose > 6 months after first shot) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant product use was provided by the reporter. No treatment medication was provided.  The patient ever received the second dose because he felt that he had 70% efficacy.
At 725 pm was extremely tired.  Went to bed.  Woke up at 1030 pm with out of control shaking and fever of 102.  Body aches and pains.  Had to put on extra clothes and blankets.  Went to work in am but had to leave early due to ongoing body pains and fever of 101.  Also, inflamed lymph node in axilla of shot arm- very painful.  Felt better by Sat late morning.  Please note I am strawberry blonde as is coworker who had same response.  Other individuals with us with very mild symptoms.
Medical assistant reporting that a patient was administered VARIVAX after a temperature excursion. No additional information provided. Additional AE cases: 02177149, 02177161, 02177162, 02177163, 02177164, 02177165, 02177166, 02177167, 02177168 filed; This spontaneous report was received from a medical assitant referring to a patient of unknown age and gender. The patient's medical history, historical drugs, concurrent conditions and concomitant medications were not provided.      On 31-MAY-2022, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) lot number U029496, expiration date 21-SEP-2023 for prophylaxis (dose and route of administration not reported) (product storage error).      The vaccine underwent a temperature excursion of 8.3 degrees Farhrenheit for 15 minutes. No previous excursions were detected.
Initial unsolicited report received from a health care professional (pharmacist) on 04-Jan-2017. This case involves a 75 year old male patient who was vaccinated with a dose of FLUZONE HD Batch number- U4764AA (expiration date, dose, dose in series and route of administration were not reported) right deltoid on 29-Sep-2016. Pre-existing physician diagnosed allergies, birth defects, medical conditions (specify) and illness at the time of vaccination was none. Any other vaccinations within four weeks of vaccinations were also none. On 29-Sep-2016, within hours of receiving the vaccine patient developed runny nose, red eyes, no taste to anything. It was reported that pharmacist advised to seek care and patient went on to an urgent care as advised. Relevant diagnostic tests/laboratory data were none Corrective treatment were not reported.The outcome of events were reported as not recovered. List of documents held by the sender: None
I was on a cruise ship and I developed a sore throat, headache, body ache, cold symptoms of a cough, and tiredness. Prior to getting on cruise, I took a COVID-19 test on 6/25/2022 that was negative with a PCR test. We brought COVID-19 test on the cruise and I took a test on 6/30/2022 that was positive. I still have these symptoms and they have not went away. I have a telehealth visit scheduled this afternoon.
The patient was given 0.5ml of the Covid19 Moderna Monovalent instead of the Bivalent.
Shots at 1210 PM. She was not nervous and was very conversant and cooperative. She had eaten breakfast. Mom and pt. walked out and showed her paperwork to office staff. Pt. fainted and fell backwards hitting head on floor. No bleeding. Complains of headache. Temp 96.1, B/P 130/60, O2 sat 99%, P 65. EMS called and arrived at 1020.
This is a spontaneous report received from a contactable consumer or other non-healthcare professional (patient). A 17-year-old patient, of an unspecified gender, received the 2nd dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, solution for injection, batch/lot# not reported), via unspecified route of administration, on an unspecified date, single dose, for COVID-19 immunization. The patient's medical history and concomitant medications not reported. Historical vaccine included the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, solution for injection, batch/lot# not reported), via unspecified route of administration, on an unspecified date, single dose, for COVID-19 immunization. On an unspecified date, patient had body aches, fatigue and fever of 101ºF. Event took place after use of product. On an unknown date, patient underwent lab tests and procedure, which included body temperature results 101ºF of fever. The outcome of the events: unknown. No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.
No symptoms prior to flu shot. Within 4 hours of flu shot, I developed a fever of 100.5. I took an Advil at bedtime, and at first seemed better on Monday morning. However, later that day, my fever returned, and for the past few days I have had fever, chills, body aches, cough, eye soreness, horseness, body itching and sore throat.
Patient did not receive 2nd dose between day 25-35 of 1st dose; Open heart surgery after the 1st dose; This spontaneous case was reported by an other caregiver and describes the occurrence of CARDIAC DISORDER (Open heart surgery after the 1st dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient did not receive 2nd dose between day 25-35 of 1st dose) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2021, the patient experienced CARDIAC DISORDER (Open heart surgery after the 1st dose). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient did not receive 2nd dose between day 25-35 of 1st dose). The patient was treated with Surgery for Cardiac disorder. At the time of the report, CARDIAC DISORDER (Open heart surgery after the 1st dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient did not receive 2nd dose between day 25-35 of 1st dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported. Treatment information was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: Follow up information received on 21-06-2021 contains No Significant information.
I discovered the MA gave a PREVNAR 13 instead of PPSV 23. No adverse outcome. No treatment to patient. Education to MA.
Received influenza vaccine on 10/10/2003.  States when woke up next day on 10/11/2003, approximately about 7:30 AM, felt shortness of breath, wheezing, headache and rapid heartbeat lasting 2 days.  Resolved on it's own.
Swelling, redness, itchy rash about 2 inches below injection site in left arm one week after injection.
Information has been received from a registered nurse concerning her 14 year old daughter with frequently injection site reaction after unspecified vaccination who was vaccinated with GARDASIL (Lot # not reported). After vaccination with GARDASIL, the patient experienced injection site reaction, she experienced redness, irritation and soreness that lasted 1 day after her second vaccination and maybe her first vaccination. Subsequently, the patient recovered from the adverse events. It was not reported whether the patient sought medical attention. This is one of several reports received from the same resource. Additional information has been requested.
TIGHTENING OF THROAT, VERTIGO - 50MG IV BENADRYL
Received the first vac on 3/12 at 8:30 a.m.. I started feeling achy and tired by 4pm. By the next day, I had diarrhea and stomach upset starting by mid day.  Since then, I have had daily diarrhea, lethargy, weakness, off and on headache, body aches (especially joints) and overall feeling of unwell.
Client c/o pain from Lt shoulder eight hours after receiving the tdap boost in the Lt Deltoid muscle. Client was seen by her Pvt MD and dx with tendonitis of the Lt shoulder. Client was told to take ibuprofen 800mg 3x a day for the pain.Client seen by MD on 03/31/09.Called client on 4/16/09 and she continues to have pain.Client states the pain had decreased a small amount and she continues to take ibuprofen. Client notified the health dept on 4/10/09 about her side effects from the Tdap vaccine
I woke up at 1:00 am feeling like I was going to get sick.  I tried to get our of bed, but was so dizzy I fell.  I was unable to stand up, so I crawled to the bathroom.  I couldn't catch my breath and my heart was racing.  I wanted to get my phone off of the counter and call for help, but I was too confused and too dizzy to get it.  I felt like I couldn't control my body.  My left arm was hurting really bad during this.  I am not sure if I fell asleep or laid there awake, but I couldn't get myself up and start making sense of things until 4 am.  I did not have any other episodes similar to this, but I did feel really tired and weak for two days.  My arm hurt really bad around injection site and through my shoulder blade for 3 days.  My symptoms are all improving now.  Just a slightly sore arm.
severe reaction with her throat closing; severe reaction with her throat closing; This is a spontaneous report from a contactable consumer.  A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRna vaccine, solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose number unknown, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced severe reaction with her throat closing. The reporter had both Moderna vaccinations. She had a friend that had taken the Pfizer vaccine also had an Event. This patient's reaction included a severe allergic reaction with her throat closing. Because of this, the individual only received 1 dose of the Pfizer vaccine. Reporter enquired was it safe to be round this friend who had the Pfizer. As Per the contact on 17May2021, reporter planned on working with an unvaccinated individual on a computer. She had been very vigilant about exposure to individuals who are not vaccinated or could be carriers for covid-19. Reporter enquired was it safe to be around this individual if they are not fully vaccinated. The events were assessed as Non serious by reporter. At the time of this report, the outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
TIREDNESS; This spontaneous report received from a patient concerned a 64 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 20-MAY-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 20-MAY-2021, the subject experienced tiredness. The action taken with covid-19 vaccine was not applicable. The patient recovered from tiredness. This report was non-serious.
71 year old male patient received an expired dose of Menactra, no AE; 71 year old male patient received an dose of Menactra, no AE; Initial information received on 03-Feb-2021 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 71 year old male patient who was vaccinated with an expired dose of vaccine MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] (expired product administered and Product administered to patient of inappropriate age).  Medical history, medical treatment, concomitant medication, vaccination and family history were not provided.  On 03-Feb-2021, the patient received a 0.5 ml dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE (lot U6521AB and expiry date: 26-Jan-2021) (frequency once) via an intramuscular route at an unknown administration site for prophylactic vaccination.  It was a case of actual medication error due to expired vaccine used and inappropriate age at vaccine administration (latency on same day).  It was also reported that description pharmacy operations manager said that they had a vial of MENACTRA that expired on 26-Jan-2021. She says that they accidentally administered the vaccine to a patient today. Caller would like to find out if the vaccine would need to be re-administered to the patient. Additional Description of event adverse events a pharmacy operations manager reporting on behalf of a consumer that received an expired dose of Menactra, on 03-Feb-2021.   Reporter relationship: (HCP) health care professional, Product used: used still using product: no  At the time of report, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Information has been received from a nurse referring to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. On 18-APR-2016 the patient was vaccinated with an improperly stored dose of MMR II (lot#I023386, expiration date 25-JUN-2017, dose and route unknown) and an improperly stored dose of (Oka/Merck) VARIVAX (lot# reported as I04688, expiration date 23-NOV-2017, dose and route unknown). The temperature and time frame were at 14.9 Celsius degree for 280 hours. There was no out of range before. No adverse events were reported. Lot number I04688 is an invalid lot number for (Oka/Merck) VARIVAX. This is one of several reports received from the same reporter. Additional information has been requested.
Fever to 104 by temporal thermometer. Down to 102.7 by removing extra blankets. Gave Tylenol. No redness, streaking or swelling. Area of immunization is not painful.
This spontaneous report as received from a physician refers to unspecified patients of unknown age and gender. Medical history and concurrent conditions were not provided. On an unknown date, the patients were vaccinated with doses of improperly stored oral, ROTATEQ (lot number K011947 expiry date 07-JUN-2016 (dose was not reported). There was no concomitant medication provided. No adverse experiences were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Pt recvd 3 doses of Engerix-B 10APR91, 10MAY91, 25OCT91 & exp no events following first 2 injects; 25OCT91 approx 4PM devel fever of 102, soreness & bruising; recvd no tx other than APAP for pain;